Results 171 to 180 of about 16,257 (211)
Some of the next articles are maybe not open access.
Nano-mupirocin: enabling the parenteral activity of mupirocin
European Journal of Nanomedicine, 2016Abstract Mupirocin is an antibiotic having a unique mode of action, not shared by any other therapeutically available antibiotic. However, due to its rapid elimination following injection and high protein binding, current therapeutic use is limited to topical administration.
Ahuva Cern +7 more
openaire +1 more source
Mupirocin-Resistant, Methicillin-ResistantStaphylococcus aureus: Does Mupirocin Remain Effective?
Infection Control & Hospital Epidemiology, 2003AbstractObjective:To determine the efficacy of mupirocin ointment in reducing nasal colonization with mupirocin-susceptible, methicillin-resistantStaphylococcus aureus(MS MRSA) as well as mupirocin-resistant MRSA (MR MRSA).Design:Prospective evaluation in which patients colonized with MRSA were treated twice daily with 2% topical mupirocin ointment for
Walker, Elaine S. +4 more
openaire +3 more sources
2017
Mupirocin, formerly called pseudomonic acid A, is a naturally occurring antibiotic that was originally isolated as a fermentation product from Pseudomonas fluorescens. It binds reversibly to the bacterial isoleucyl transfer-RNA synthetase and thereby inhibits bacterial protein and RNA synthesis, ultimately leading to bacterial death (Poovelikunnel et ...
Verkaik, Nelianne J., Vos, Margreet C.
openaire +1 more source
Mupirocin, formerly called pseudomonic acid A, is a naturally occurring antibiotic that was originally isolated as a fermentation product from Pseudomonas fluorescens. It binds reversibly to the bacterial isoleucyl transfer-RNA synthetase and thereby inhibits bacterial protein and RNA synthesis, ultimately leading to bacterial death (Poovelikunnel et ...
Verkaik, Nelianne J., Vos, Margreet C.
openaire +1 more source
Transferable mupirocin-resistance
Journal of Antimicrobial Chemotherapy, 1988W C, Noble +3 more
openaire +2 more sources